Publications

Detailed Information

CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo

Cited 30 time in Web of Science Cited 34 time in Scopus
Authors

Yoon, Hyung Ho; Ye, Sunghyeok; Lim, Sunhwa; Jo, Ara; Lee, Hawon; Hong, Felix; Lee, Seung Eun; Oh, Soo-Jin; Kim, Na-Rae; Kim, Kyoungmi; Kim, Bum-Joon; Kim, Hyunjin; Lee, C. Justin; Nam, Min-Ho; Hur, Junseok W.; Jeon, Sang Ryong

Issue Date
2022-02
Publisher
MARY ANN LIEBERT, INC
Citation
CRISPR JOURNAL, Vol.5 No.1, pp.95-108
Abstract
Mutations in specific genes, including synuclein alpha (SNCA) that encodes the alpha-synuclein protein, are known to be risk factors for sporadic Parkinson's disease (PD), as well as critical factors for familial PD. In particular, A53T-mutated SNCA (A53T-SNCA) is a well-studied familial pathologic mutation in PD. However, techniques for deletion of the mutated SNCA gene in vivo have not been developed. Here, we used the CRISPR-Cas9 system to delete A53T-SNCA in vitro as well as in vivo. Adeno-associated virus carrying SaCas9-KKH with a single-guide RNA targeting A53T-SNCA significantly reduced A53T-SNCA expression levels in vitro. Furthermore, we tested its therapeutic potential in vivo in a viral A53T-SNCA-overexpressing rat model of PD. Gene deletion of A53T-SNCA significantly rescued the overexpression of alpha-synuclein, reactive microgliosis, dopaminergic neurodegeneration, and parkinsonian motor symptoms. Our findings propose CRISPR-Cas9 system as a potential prevention strategy for A53T-SNCA-specific PD.
URI
https://hdl.handle.net/10371/218783
DOI
https://doi.org/10.1089/crispr.2021.0025
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Veterinary Medicine
  • Department of Veterinary Medicine
Research Area

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share